AlménT.: Contrast agent design. J. theor. Biol.24 (1969), 216.
2.
AlménT.Experience from 10 years of development of water-soluble nonionic contrast media. Invest. Radiol.15 (1980), 283.
3.
BinzA.: The chemistry of Uroselectan. Brit. J. Urol.2 (1930), 348.
4.
BraschR. C.CaldwellJ. L.FudenbergH. H.: Antibodies to radiographic contrast agents. Induction and characterization of rabbit antibody. Invest. Radiol.11 (1976), 1.
5.
BromanT.OlssonO.: The tolerance of cerebral blood vessels to a contrast medium of the diodrast group. Acta radiol.30 (1948), 326.
6.
BrooksW. W.PaulinS.BingO. H. L.LaraiaP. J.: Effect of angiographic contrast agents on the mechanical performance of the isolated rat papillary muscle preparations. Invest. Radiol.15 (1980), 203.
7.
CampD. C.VoegeleA. L.FriesenR. D.KaufmanL.HruskaB.: An automated sample changer for X-ray fluorescence analysis. Chem. Instrum.7 (1976), 47.
8.
EriksonU.CullhedJ.HelmiusG.RuhnG.: Erfahrungen mit Amipaque® und Isopaque Coronar® bei der Koronararteriographie. Ein Vergleich. In: Amipaque Workshop Berlin 1978, p. 108. Excerpta Medica, Amsterdam 1978.
9.
FelderE.: Preclinical studies with a new non-ionic contrast agent. Second Congress of the European Society of Cardiovascular Radiology, Uppsala 1977.
10.
FischerH. W.MorrisT. W.: Possible factors in intravascular contrast media toxicity. Invest. Radiol.15 (1980), 232.
11.
GolmanK.AlménT.: Metrizamide in experimental urography. 1. Iodine concentration and flow of urine following intravenous injections of an ionic and a non-ionic contrast medium in rabbits. Acta radiol. (1973) Suppl. No. 335, p. 312.
12.
GolmanK.AlménT.HoltåsS.: Proteinuria produced by urographic contrast media. Invest. Radiol.15 (1980), 61.
13.
GonsetteR. E.André-BalisauxG.: La perméabilité des vaisseaux cérébraux. Etude de la tolérance pour les produits de contraste. Acta radiol. (1967) Suppl. No. 270, p. 228.
14.
GonsetteR. E.André-BalisauxG.LiesenborghL.: New contrast media in cerebral angiography. Animal experiments and preliminary clinical studies. Invest. Radiol.15 (1980), 270.
HigginsC. B. (a): Effects of contrast materials on left ventricular function. Invest. Radiol.15 (1980), 220.
17.
HigginsC. B. (b): Overview and methods used for the study of the cardiovascular actions of contrast materials. Invest. Radiol.15 (1980), 188.
18.
HigginsC. B.SchmidtW.: Alterations in calcium levels of coronary sinus blood during coronary arteriography in the dog. Circulation58 (1978), 512.
19.
HoltåsS.TejlerL.: Proteinuria following nephroangiography. IV. Comparison in dogs between ionic and non-ionic contrast. Acta radiol. Diagnosis20 (1979), 13.
OstendorfP.FreundM.WalterE.WolfK.-J.: Veränderungen der Blutgerinnung durch Katheterangiographie nach Injektion von Megluminamidotrizoat (Angiografin® 65%) und Metrizamid (Amipaque®). In: Amipaque Workshop Berlin 1978, p. 151. Excerpta Medica, Amsterdam 1978.
RaininkoR.: Role of hypertonicity in the endothelial injury caused by angiographic contrast media. Acta radiol. Diagnosis20 (1979), 410.
27.
RanganathanR.SovakM.: Syntheses of new non-ionic radiographic contrast media: Acylamino-triiodophenyl ethers of sugars. Invest. Radiol.15 (1980), 296.
28.
RosenbergF. J.RomanoJ. J.ShawD. D.: Metrizamide, iothalamate, and metrizoate. Effects of internal carotid arterial injections on the blood-brain barrier of the rabbit. Invest. Radiol.15 (1980), 275.
29.
SchmittA. E.BurkartF.BertelO.: Laevokardiographie mit Metrizamid. In: Amipaque Workshop Berlin 1978, p. 115. Excerpta Medica, Amsterdam 1978.
30.
SerurJ. R.AlsA. V.Miner-GreenN.PaulinS.: Comparative effects of three radiographic contrast agents in isolated normal and isechemic canine hearts. Invest. Radiol.15 (1980), 196.
31.
ShehadiW. H.TonioloG.: Adverse reactions to contrast media. Radiology137 (1980), 299.
32.
SkalpeI. O.EvensenA.: Toxicity of metrizamide, meglumine iocarmate and sodium metrizoate in selective nephroangiography. Acta radiol. (1973) Suppl. No. 335, p. 175.
33.
SovakM.RanganathanR.LangJ. H.LasserE. C.: Concepts in design of improved intravascular contrast agents. Ann. Radiol.21 (1978), 283.
34.
SpeckU.SieffertH.-M.KlinkG.: Contrast media and pain in peripheral arteriography. Invest. Radiol.15 (1980), 335.
35.
TrägårdhB.: Investigation of the effects of new contrast media on myocardial function. Invest. Radiol.15 (1980), 194.
36.
WalterE.WolfK.-J.HippeliR.OstendorfP.: Metrizamid und Megluminamidotrizoat zur retrograden Beinarteriographie. Eine klinisch-radiologisch-laborchemische Vergleichsstudie. In: Amipaque Workshop Berlin 1978, p. 144. Excerpta Medica, Amsterdam 1978.
37.
WolfG. L.: The fibrillatory propensities of contrast agents. Invest. Radiol.15 (1980), 208.